Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Ei, Minder"'
Autor:
X Schneider-Yin, EI Minder
Publikováno v:
Swiss Medical Weekly, Vol 136, Iss 3132 (2006)
Externí odkaz:
https://doaj.org/article/05b505ac597848a28dcb15584e21d2eb
Autor:
Macé M. Schuurmans, Schneider-Yin X, Ub, Rüfenacht, Schnyder C, Ce, Minder, Puy H, Jc, Deybach, Ei, Minder
Publikováno v:
Europe PubMed Central
BACKGROUND: Acute intermittent porphyria (AIP) is an inherited disorder in the heme biosynthetic pathway caused by a partial deficiency of porphobilinogen (PBG) deaminase. Clinically, AIP is characterized as acute neurovisceral attacks that are often
Autor:
Minder AE; Division of Endocrinology, Diabetology, and Porphyria, Stadtspital Zürich Triemli, Zurich, Switzerland.; Swiss Reference Centre for Porphyrias, Stadtspital Zürich Triemli, Zurich, Switzerland., Kluijver LG; Department of Internal Medicine, Porphyria Center Rotterdam, Center for Lysosomal and Metabolic Disease, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Barman-Aksözen J; Swiss Reference Centre for Porphyrias, Stadtspital Zürich Triemli, Zurich, Switzerland.; Institute of Laboratory Medicine, Stadtspital Zürich Triemli, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland., Minder EI; Division of Endocrinology, Diabetology, and Porphyria, Stadtspital Zürich Triemli, Zurich, Switzerland.; Swiss Reference Centre for Porphyrias, Stadtspital Zürich Triemli, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland., Langendonk JG; Department of Internal Medicine, Porphyria Center Rotterdam, Center for Lysosomal and Metabolic Disease, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Jul 16. Date of Electronic Publication: 2024 Jul 16.
Autor:
Belosevic A; Institute of Laboratory Medicine, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland., Minder AE; Division of Endocrinology, Diabetology, Porphyria and Clinical Nutrition, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Swiss Reference Centre for Porphyrias, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland., Gueuning M; Department of Research and Development, Blood Transfusion Service Zurich, Swiss Red Cross, 8952 Schlieren, Switzerland., van Breemen F; Institute of Laboratory Medicine, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Swiss Reference Centre for Porphyrias, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland., Thun GA; Department of Research and Development, Blood Transfusion Service Zurich, Swiss Red Cross, 8952 Schlieren, Switzerland., Mattle-Greminger MP; Department of Research and Development, Blood Transfusion Service Zurich, Swiss Red Cross, 8952 Schlieren, Switzerland., Meyer S; Department of Molecular Diagnostics and Cytometry, Blood Transfusion Service Zurich, Swiss Red Cross, 8952 Schlieren, Switzerland., Baumer A; Institute of Medical Genetics, University of Zürich, 8952 Schlieren, Switzerland., Minder EI; Division of Endocrinology, Diabetology, Porphyria and Clinical Nutrition, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Swiss Reference Centre for Porphyrias, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland., Schneider-Yin X; Institute of Laboratory Medicine, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Swiss Reference Centre for Porphyrias, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland., Barman-Aksözen J; Institute of Laboratory Medicine, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Swiss Reference Centre for Porphyrias, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.
Publikováno v:
Life (Basel, Switzerland) [Life (Basel)] 2023 Sep 10; Vol. 13 (9). Date of Electronic Publication: 2023 Sep 10.
Autor:
Vielhaber JA; Division of Endocrinology, Diabetology, Porphyria and Clinical Nutrition, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland., Barman-Aksözen J; Swiss Reference Center for Porphyrias, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland.; Institute of Laboratory Medicine, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland., Minder EI; Division of Endocrinology, Diabetology, Porphyria and Clinical Nutrition, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland.; Swiss Reference Center for Porphyrias, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Schneider-Yin X; Swiss Reference Center for Porphyrias, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland.; Institute of Laboratory Medicine, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland., Zulewski H; Division of Endocrinology, Diabetology, Porphyria and Clinical Nutrition, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland.; Department of Biosystems Science and Engineering (D-BSSE), ETH, Zurich, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland., Minder AE; Division of Endocrinology, Diabetology, Porphyria and Clinical Nutrition, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland. anna.minder@stadtspital.ch.; Swiss Reference Center for Porphyrias, Stadtspital Zurich Triemli, Birmensdorferstrasse 497, Zurich, Switzerland. anna.minder@stadtspital.ch.
Publikováno v:
Obesity surgery [Obes Surg] 2023 May; Vol. 33 (5), pp. 1600-1602. Date of Electronic Publication: 2023 Apr 01.
Autor:
Minder AE; Division of Endocrinology, Diabetology, Porphyria and Clinical Nutrition, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Swiss Reference Centre for Porphyrias, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland., Schneider-Yin X; Swiss Reference Centre for Porphyrias, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Institute of Laboratory Medicine, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland., Zulewski H; Division of Endocrinology, Diabetology, Porphyria and Clinical Nutrition, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Department of Biosystems Science and Engineering (D-BSSE), ETH, 8092 Zurich, Switzerland.; Faculty of Medicine, University of Basel, 4001 Basel, Switzerland., Minder CE; Department of Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland., Minder EI; Division of Endocrinology, Diabetology, Porphyria and Clinical Nutrition, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Swiss Reference Centre for Porphyrias, Stadtspital Zürich, Triemli, 8063 Zurich, Switzerland.; Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Publikováno v:
Life (Basel, Switzerland) [Life (Basel)] 2023 Apr 21; Vol. 13 (4). Date of Electronic Publication: 2023 Apr 21.
Autor:
Collaud E; Division of Neurorehabilitation, Fribourg Hospital Meyriez/Murten, Fribourg, Switzerland., Wittwer L; Division of Neurorehabilitation, Fribourg Hospital Meyriez/Murten, Fribourg, Switzerland.; Division of Medicine, Emmental Hospital, Burgdorf, Switzerland., Minder AE; Division of Endocrinology, Diabetology, Porphyria, Triemli Hospital, Zurich, Switzerland., Annoni JM; Neurology Unit, Laboratory for Cognitive and Neurological Science, Department of Neuroscience and Movement Science, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland., Minder EI; Division of Endocrinology, Diabetology, Porphyria, Triemli Hospital, Zurich, Switzerland., Chabwine JN; Division of Neurorehabilitation, Fribourg Hospital Meyriez/Murten, Fribourg, Switzerland.; Neurology Unit, Laboratory for Cognitive and Neurological Science, Department of Neuroscience and Movement Science, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Publikováno v:
Frontiers in genetics [Front Genet] 2022 Oct 31; Vol. 13, pp. 993453. Date of Electronic Publication: 2022 Oct 31 (Print Publication: 2022).
Autor:
Minder AE; Division of Endocrinology, Diabetology, Porphyria, Stadtspital Zürich, Birmensdorferstrasse 497, 8063 Zurich, Switzerland., Barman-Aksoezen J; Institute of Laboratory Medicine, Stadtspital Zürich, Zurich, Switzerland., Schmid M; Department of Hematology and Oncology, Stadtspital Zürich, Zurich, Switzerland., Minder EI; Division of Endocrinology, Diabetology, Porphyria, Stadtspital Zürich, Zurich, Switzerland., Zulewski H; Division of Endocrinology, Diabetology, Porphyria, Stadtspital Zürich, Zurich, Switzerland., Minder CE; Department of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Schneider-Yin X; Institute of Laboratory Medicine, Stadtspital Zürich, Zurich, Switzerland.
Publikováno v:
Therapeutic advances in rare disease [Ther Adv Rare Dis] 2021 Dec 21; Vol. 2, pp. 26330040211065453. Date of Electronic Publication: 2021 Dec 21 (Print Publication: 2021).
Autor:
Halloy F; Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland., Iyer PS; Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland., Ghidini A; Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland., Lysenko V; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, 8091 Zurich, Switzerland., Barman-Aksözen J; Institute of Laboratory Medicine, Municipal Hospital Waid and Triemli, 8063 Zurich, Switzerland., Grubenmann CP; Institute of Laboratory Medicine, Municipal Hospital Waid and Triemli, 8063 Zurich, Switzerland., Jucker J; Institute of Laboratory Medicine, Municipal Hospital Waid and Triemli, 8063 Zurich, Switzerland., Wildner-Verhey van Wijk N; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, 8091 Zurich, Switzerland., Ruepp MD; UK Dementia Research Institute at King's College London, SE5 9RT London, UK; Institute of Psychiatry, Psychology and Neuroscience, King's College London, SE5 8AF London, UK., Minder EI; Department for Endocrinology, Diabetology, Porphyria, Municipal Hospital Waid and Triemli, 8063 Zurich, Switzerland., Minder AE; Department for Endocrinology, Diabetology, Porphyria, Municipal Hospital Waid and Triemli, 8063 Zurich, Switzerland., Schneider-Yin X; Institute of Laboratory Medicine, Municipal Hospital Waid and Triemli, 8063 Zurich, Switzerland., Theocharides APA; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, 8091 Zurich, Switzerland., Schümperli D; Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland. Electronic address: daniel.schuemperli@pharma.ethz.ch., Hall J; Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland. Electronic address: jonathan.hall@pharma.ethz.ch.
Publikováno v:
Cell chemical biology [Cell Chem Biol] 2021 Aug 19; Vol. 28 (8), pp. 1221-1234.e6. Date of Electronic Publication: 2021 Mar 22.
Autor:
Biolcati G; Centre for Porphyrias, Istituto Dermatologico S. Gallicano - Istituti Fisioterapici Ospitalieri, Rome, Italy., Hanneken S; Private Practice Empoderm, Düsseldorf, Germany., Minder EI; Stadtspital Triemli, Porphyria Outpatient Clinics, Zurich, Switzerland., Neumann NJ; Department of Dermatology, Heinrich Heine University, Duesseldorf, Germany., Wilson JHP; The Department of Internal Medicine, Center of Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, Netherlands., Wolgen PJ; Clinuvel Pharmaceuticals Limited, Melbourne, Australia., Wright DJ; Clinuvel Pharmaceuticals Limited, Melbourne, Australia., Lloyd AJ; Acaster Lloyd Consulting Ltd, London, UK. andrew.lloyd@acasterlloyd.com.
Publikováno v:
Journal of patient-reported outcomes [J Patient Rep Outcomes] 2021 Aug 15; Vol. 5 (1), pp. 73. Date of Electronic Publication: 2021 Aug 15.